共 48 条
[11]
Menichelli M(2020)Comparison between Ticagrelor versus Clopidogrel in Long Term Outcomes of Taiwanese Diabetic Subjects with Acute Coronary Syndrome Undergoing Successful Revascularization: From TSOC ACS-DM Registry Medicine (Baltimore) 99 835-1988
[12]
Ndrepepa G(2020)Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study Circulation 142 1981-2273
[13]
Kastrati A(2016)Clopidogrel versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated with Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients) Circulation 134 2261-1320
[14]
Menichelli M(2017)Antithrombotic Potency of Ticagrelor versus Clopidogrel in Type-2 Diabetic Patients with Cardiovascular Disease Thromb Haemost 117 1309-undefined
[15]
Stang A(2013)Consensus and Update on the Definition of on-Treatment Platelet Reactivity to Adenosine Diphosphate Associated with Ischemia and Bleeding J Am Coll Cardiol 62 undefined-undefined
[16]
Page MJ(2019)Ticagrelor in Patients with Stable Coronary Disease and Diabetes N Engl J Med 381 undefined-undefined
[17]
McKenzie JE(undefined)undefined undefined undefined undefined-undefined
[18]
Bossuyt PM(undefined)undefined undefined undefined undefined-undefined
[19]
He P(undefined)undefined undefined undefined undefined-undefined
[20]
Luo X(undefined)undefined undefined undefined undefined-undefined